HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Rapid cycling--finally stable but obese--target acquired?].

Abstract
Overweight and obesity are common in patients with bipolar disorder. Rates of up to 70% are described in scientific publications. There is sufficient evidence that these conditions are associated with a worse course of the disease (more episodes, higher suicide and hospitality rates, worse response to lithium, somatic comorbidities). Most of the mood stabilisers lead to weight gain. This is also true for clozapine, which can be effective in therapy-refractory courses of bipolar disorder. This case report demonstrates the complexity of the treatment of bipolar disorder. A young patient in depressive stupor following a severe suicide attempt after 5 months of hospital treatment was sent to our department to perform ECT. This was not possible because of the severity of his injuries. We were able to cure the acute condition and interrupt the course of rapid cycling with a combination of clomipramine, lithium and clozapine. A stable course of four years under this medication and psychoeducation has been achieved. In this period the patient was able to lower his body mass index from 38 to 26 because of a consequent lifestyle modification.
AuthorsB Reininghaus, S A Bengesser, E Reininghaus, N Lackner, H P Kapfhammer, A Birner
JournalFortschritte der Neurologie-Psychiatrie (Fortschr Neurol Psychiatr) Vol. 82 Issue 12 Pg. 701-5 (Dec 2014) ISSN: 1439-3522 [Electronic] Germany
Vernacular TitleRapid Cycling--Endlich stabil aber adipös--Ziel erreicht?
PMID25489759 (Publication Type: Case Reports, English Abstract, Journal Article)
Copyright© Georg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Antimanic Agents
  • Antipsychotic Agents
  • Clozapine
Topics
  • Antimanic Agents (adverse effects, therapeutic use)
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Bipolar Disorder (complications, drug therapy, therapy)
  • Clozapine (adverse effects, therapeutic use)
  • Humans
  • Male
  • Obesity (complications, therapy)
  • Overweight (complications, therapy)
  • Suicide, Attempted
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: